The FG provides support to Early Career Scientists and acts as a platform for bridging the gap between industry and academia.
Webinars
The FG webinar series will explore different topics. Dedicated webinars will be organised by our FG once a month, that will consist by 2 talks (30 min each with questions).
Professor of Pharmaceutical Material Science and Technology at the School of Pharmacy of the University of East Anglia. Prof. Qi’s lab has great interests in pharmaceutical material sciences and processing. By working with industrial partners as well as cross-discipline collaborators, her group is aiming to contribute to the interdisciplinary research area of enhancing drug absorption via tailoring the physical chemistry of drug formulations. Recently through the support of UEA Health and Social Care Partners, she founded UEAHSCP Point of Care 3D Printing Research Group to allow the scientists from UEA and other academic collaborators to work with clinicians, pharmacists, and patients to identify and develop efficient and cost-effective uses of 3D printing in acute hospital environments. https://research-portal.uea.ac.uk/en/persons/sheng-qi
I am a student representative on the APS Emerging technologies focus group. I am currently beginning my third year of studies in my PhD at Queen’s University Belfast with my main interest being in additive manufacturing. My interest in the field of 3D printing began during my undergraduate degree in Pharmaceutical Science, where I was able to undergo a year long research project in the area of Fused Deposition Modelling for fabrication of drug eluding catheters. This gave me a great insight into research culture and the area of 3D Printing. I then applied for a PhD position within Queens University due to my desire to continue in the area of research and additive manufacturing. Currently my research is focusing on the use of resin based 3D printing for transdermal drug delivery devices. I have been developing 3D printed microneedle arrays using Digital Light Processing, with expertise in other methods of 3D printing including Fused deposition modelling, Stereolith...
Atheer is the APS Emerging Technologies Focus Group’s Post-doc representative. Atheer received her Bachelor’s degree in Pharmacy from Applied Science University in Jordan. She then pursued an MSc in Pharmaceutics at UCL School of Pharmacy, University College of London, where her research was aimed at exploring the potential of 3D printing for the formulation of abuse-deterrent and alcohol-resistant formulations. Earlier this year, she completed a PhD in Pharmaceutics at the same institution where her research was focused on fabrication of novel, bespoke pharmaceutical dosage forms using 3D printing. Currently, Atheer is working as a Research Fellow at UCL School of Pharmacy as part of the Interreg 2 Seas Mers Zeeën project for site-specific drug delivery, looking into using 3D printing to improve colonic drug delivery. She is one of youngest and leading researchers on the 3D printing of pharmaceuticals. In the past three years, she has published over 20 pap...
Comments
Post a Comment